Mirel Sanchez, MD
Family Medicine · Miami, FLNPI 1740401322
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,105 of the $12,664 with a category attached, or 79.8%. It is spread thinly across 32 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 477 payments — averaging $26.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Madrigal Pharmaceuticals$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Lilly USA, LLC$917
- Janssen Research & Development, LLC$893
- Johnson & Johnson$844
- plus $5K from 26 others
Across 297 payments — averaging $8326.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$802K
- Boehringer Ingelheim$526K
- Sanofi US Services Inc.$476K
- Eli Lilly$182K
- Janssen Research & Development, LLC$180K
- Boehringer Ingelheim International GmbH$119K
- plus $187K from 8 others
What the payments were for
- Travel & lodging$2,51420%
- Food & beverage$10,10580%
- Education$440%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 84 | $1,888 |
| Madrigal Pharmaceuticals | 7 | $1,796 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 58 | $1,072 |
| Lilly USA, LLC | 61 | $917 |
| Janssen Research & Development, LLC | 7 | $893 |
| Johnson & Johnson | 39 | $844 |
| Novo Nordisk | 42 | $801 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $722 |
| Sanofi-aventis U.S. LLC | 23 | $447 |
| Boehringer Ingelheim | 22 | $431 |
| Pfizer | 20 | $399 |
| Amgen(2 entities) | 20 | $363 |
| GSK | 10 | $277 |
| Bayer | 11 | $249 |
| Corcept Therapeutics | 8 | $243 |
| Kowa Pharmaceuticals America, Inc. | 4 | $161 |
| Exact Sciences | 6 | $160 |
| Amarin Pharma, Inc. | 8 | $148 |
| Abbott | 7 | $145 |
| Merck | 7 | $142 |
| Inspire Medical Systems, Inc. | 1 | $140 |
| Astellas Pharma US Inc | 4 | $76 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| Novartis | 3 | $55 |
| Phadia US Inc. | 3 | $53 |
| Radius Health, Inc. | 3 | $47 |
| Evoke Pharma, Inc. | 2 | $31 |
| Insulet Corporation | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,664 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 40 | $26,705 |
| EliquisApixaban | 40 | $26,652 |
| XareltoRivaroxaban | 46 | $26,245 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 22 | $18,034 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 21 | $16,856 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 29 | $16,696 |
| TradjentaLinagliptin | 26 | $15,422 |
| FarxigaDapagliflozin Propanediol | 16 | $14,050 |
| JardianceEmpagliflozin | 15 | $12,661 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $11,228 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $9,094 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 22 | $8,482 |
| BrilintaTicagrelor | 18 | $7,967 |
| MyrbetriqMirabegron | 11 | $5,083 |
| Semglee (Yfgn) PenInsulin Glargine-Yfgn | 11 | $4,296 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSynjardy Xr, Tradjenta, Jardiance | $431 | $44,93862 claims |
| MerckJanuvia, Janumet Xr | $142 | $35,18762 claims |
| GSKAnoro Ellipta, Trelegy Ellipta | $277 | $27,92446 claims |
| PfizerEliquis | $399 | $26,65240 claims |
| Johnson & JohnsonXarelto | $844 | $26,24546 claims |
| AstraZenecaFarxiga, Brilinta | $1,888 | $22,01834 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $447 | $18,03422 claims |
| Astellas Pharma US IncMyrbetriq | $76 | $5,08311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Miami
- Clifford KinderMiami$75K
- Robert GoubeauxMiami$67K
- Vanessa RojasMiami$50K
- Michelle PowellMiami$34K
- Ana EloseguiMiami$32K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.